Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-18

FDA Approved: NARCAN — Original Application (Emergent Devices Inc.)

View source ↗

Summary

FDA approved Narcan nasal naloxone under an original application by Emergent Devices Inc. for rapid treatment of opioid overdose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NARCAN (Naloxone hydrochloride nasal)

Snippet

ORIG AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)